tiprankstipranks
Anebulo Pharmaceuticals, Inc. (ANEB)
:ANEB
US Market

Anebulo Pharmaceuticals (ANEB) Income Statement

Compare
24 Followers

Anebulo Pharmaceuticals Income Statement

Last quarter (Q2 2025), Anebulo Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Anebulo Pharmaceuticals's net income was $-2.46M. See Anebulo Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 8.31M$ 11.78M$ 6.83M$ 3.61M$ 173.35K
Depreciation and Amortization
$ 258.28K$ 11.78M$ 6.83M$ 3.61M$ 1.04M
EBITDA
$ -8.05M$ -11.78M$ 5.55K$ -30.24M$ -173.35K
Operating Income
$ -8.31M$ -11.78M$ -6.83M$ -3.61M$ -173.35K
Other Income/Expenses
$ 107.05K$ 51.26K$ 5.55K$ -26.64M$ -1.29K
Pretax Income
$ -8.20M$ -11.73M$ -6.83M$ -30.25M$ -174.64K
Net Income
$ -8.20M$ -11.73M$ -6.81M$ -30.26M$ -174.64K
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.32$ -0.47$ -0.29$ -1.30$ -0.01
Diluted EPS
$ -0.32$ -0.47$ -0.29$ -1.30$ -0.01
Weighted Average Shares Outstanding
25.82M 25.07M 23.34M 23.34M 23.72M
Weighted Average Shares Outstanding (Diluted)
25.82M 25.07M 23.34M 23.34M 23.72M
Currency in USD

Anebulo Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis